Larimar Therapeutics, Inc. <LRMR.O>: Leerink Partners Assumes Coverage With Outperform Rating; Target Price $13 vs $12
LRMR•Related News
VisionWave files US patent for ARGUS space-enabled, AI-driven counter-drone defense architecture
VWAV•
Lyntris Inc. <LYNX.N>: Raymond James initiates coverage with outperform rating; price target $18
LYNX•
Curaleaf asks Alberta regulator to halt Aurora ATM share sales during US$4 offer
CURLF•
US Stocks-Nasdaq futures slide as AI warnings rattle markets; Nvidia, other chip stocks retreat
SPY•
Hain Celestial Q4 sales miss estimates on divestiture impact
HAIN•